Previous 10 | Next 10 |
Healthcare research is laying the groundwork for drug technology that has never been seen before. By improving product efficacy and safety, as well as patient convenience and compliance, drugs are becoming more sophisticated with every passing year. Novel drug delivery technologies must overcom...
Alcon, Inc. (ALC) Q2 2019 Earnings Conference Call August 21, 2019 8:00 AM ET Company Participants Karen King – Senior Vice President of Investor Relations and Communications David Endicott – Chief Executive Officer Tim Stonesifer – Chief Financial Officer ...
Image source: The Motley Fool. Alcon, Inc. (NYSE: ALC) Q2 2019 Earnings Call Aug. 21, 2019, 8:00 a.m. ET Operator Continue reading
The following slide deck was published by Alcon, Inc. in conjunction with their 2019 Q2 earnings Read more ...
Alcon (NYSE: ALC ) Q2 results : More news on: Alcon, Inc., Healthcare stocks news, Earnings news and commentary, Read more ...
Alcon (NYSE: ALC ): Q2 Non-GAAP EPS of $0.47 misses by $0.01 ; GAAP EPS of -$0.80 misses by $0.76 . Revenue of $1.86B (+2.2% Y/Y) in-line. Press Release More news on: Alcon, Inc., Earnings news and commentary, Healthcare stocks news,
Second quarter sales of $1.9 billion, an increase of 2%, or 5% constant currency (cc) Announced the launch of PRECISION1, a new daily SiHy lens designed for the mainstream market Second quarter mid-single digit growth in all product categories (cc) Reiterated full...
PRECISION1 is the first mainstream daily disposable contact lens to use SMARTSURFACE Technology to deliver lasting visual performance and comfort 1 New clinical data show five times more contact lens wearers “strongly preferred” PRECISION1 vs. 1-Day ACUVUE Moist 2 I...
This article is part of a series that provides an ongoing analysis of the changes made to Tweedy Browne’s 13F portfolio on a quarterly basis. It is based on Tweedy Browne’s regulatory 13F Form filed on 08/05/2019. Please visit our Tracking Tweedy Browne Portfolio series to ge...
This article is part of a series that provides an ongoing analysis of the changes made to Kahn Brothers’ 13F stock portfolio on a quarterly basis. It is based on Kahn Brothers’ regulatory 13F Form filed on 08/05/2019. Please visit our Tracking Kahn Brothers Portfolio series t...
News, Short Squeeze, Breakout and More Instantly...
2024-07-29 17:18:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Combined vitreoretinal-cataract system (VCS) and standalone cataract system (CS) are cleared for use in the U.S. New, proprietary technologies designed to deliver transformative surgical innovation Alcon to immediately begin collecting real-world user experience in the U.S. prior ...
2024-06-09 17:38:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...